Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.
| Last: | $3.31 |
|---|---|
| Change Percent: | -5.7% |
| Open: | $3.34 |
| Close: | $3.51 |
| High: | $3.3806 |
| Low: | $3.25 |
| Volume: | 4,190 |
| Last Trade Date Time: | 03/06/2026 12:08:44 pm |
| Market Cap: | $11,164,462 |
|---|---|
| Float: | 3,034,410 |
| Insiders Ownership: | N/A |
| Institutions: | 8 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.imunon.com |
| Country: | US |
| City: | Lawrenceville |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Imunon Inc. (NASDAQ: IMNN).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
